Top Tweets for #LSALT
The National Research Council of Canada is providing ($4 Million) funding for the development of #Lsalt peptide drug program.
This further validates the new mechanism of action in the eyes of third party academic experts! $Arch.v $Achff @archbiopartners
https://t.co/g1Jt5xYKvE
With a successful Phase II trial fully funded by the Government of Canada @archbiopartners new Mechanism of Action #Metablok #LSALT is a possible treatment for the unmet #AKI market.#Lung #Liver #Kidney #organinflammation
Currently enrolled in a Phase III trial.
$Arch.v $Achff
The drugs companies currently dosing in the @WHO Solidarity Phase III @CATCOtrial. $Arch.v $Achff
Market Cap:
@Novartis -260B
@archbiopartners -260M 👈
@Merck -222B
#LSALT New fully patented Mechanism of Action that has reduced ventilation time by 6.7 days in Phase II trial.
The Phase III @CATCOtrial lists @archbiopartners lead drug candidate #LSALT. $Arch.v $Achff current market cap of $258m CAN. The peers on the trial all have value of Billions US. This NEW fully patented Mechanism of Action works in #Lung #Liver #Kidney👈
https://t.co/fTnYuuJhbF
Congratulations to @archbiopartners on the Phase III approval from Health Canada for #metablok / #Lsalt ! $Arch.v $achff @CATCOtrial
Huge news out on $Arch.v , with yet another third party publication on #metablok #Lsalt . One must remember that although in fully funded phase III @CATCOtrial , @archbiopartners is an organ inflammation trial, with a 20 billion unmet kidney market.
With a signal from the recent Phase II results, It is very exciting to review historic (Now proven) Mechanism of Action material from Dipeptidase-1 ( #Metablok / #Lsalt ). Exciting future ahead for @archbiopartners in the #Lung #Liver & #Kidney #NovelTherapeutic
$Arch.v $Achff
Congratulations to @archbiopartners with the progression of #Lsalt peptide. This novel therapeutic is a real Canadian success story in the battle of #Covid_19
$Arch.v $Achff
@kinsellawarren The Canadian Government invested in the development of a novel therapeutic last year. #Lsalt was recommended by Canada's top scientists in the war against the #coronavirus . #Lung #Liver #Kidney need help with inflammation to reduce hospitalizations.
$Arch.v
@archbiopartners is currently waiting on Phase II results for #LSALT , one of the only novel therapeutics that has advanced during #COVID19 for respiratory issues. The #VariantsofConcern is another reason why #Therapeutics are the way out of this pandemic. $Arch.v #Lung #Kidney
Dow futures plunge 400 points amid fears of new Covid variant found in South Africa https://t.co/Af7ZT3Kbwv
With @archbiopartners Phase II trial currently having Data reviewed by a third party, the stock is currently trading at 182 mil (US) market cap with the potential to treat a 20 billion/year unmet market. #LSALT #Metablok #Lung #Liver #Kidney #inflammation
$Arch.v #StocksToBuy
@archbiopartners third party data analysis expected to occur during the latter part of July #Metablok #Lsalt . Potential progress in therapeutics for #inflammation , Phase II results could be a game changer in the #Lung #Liver #Kidney #COVID19 . $Arch.v $Achff
@archbiopartners CSO quoted in an interview “Early data on the drug is positive”. This early indication is beyond exciting for a NEW Canadian Mechanism of Action #covid19 #metablok #Lsalt #inflammation #lung #liver #kidney #humantrials $Arch.v
https://t.co/oA4lLakoDs
@archbiopartners receives ethics committee approval in Turkey to dose additional patients in the phase II trial for #LSALT Peptide. #Metablok #Inflammation #Lung #liver #Kidney #Phase2
$Arch.v
Very Exciting News for this MADE IN CANADA therapeutic. @archbiopartners $Arch.v #LSALT #METABLOK #KIDNEYINFLAMMATION
University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
https://t.co/cgPEpCMqsU
Arch Biopartners Announces Dosing of First Patient in #Turkey in #Phase2Trial of LSALT peptide (#Metablok) to Treat Complications from #COVID19
Full Release: https://t.co/sorkn731r1
https://t.co/T2XOrLthip
Another @archbiopartners Technology in the news this week! #MetaMX and #LSALT. Exciting times for $Arch.v Shareholders
#pressrelease Sept 1, 2020 - Arch Biopartners Announces Application to the Turkish Ministry of Health to Conduct #Phase2 Trial for Treatment of Complications in #COVID19 patients...
Full release here: https://t.co/iN9I0MR1eQ
#inflammation #lung #kidney #liver
Upcoming Public Webinar 18 Aug, 11am - Key science and management team overview of Metablok and our #Phase2 trial human trial to treat #inflammation in patients with severe complications from #Covid19.
Find out more and register to attend this free event:
https://t.co/rcQ8ygtrre
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.3M followers
Bill Gates
@billgates
65.1M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers